Literature DB >> 27222921

Structural and Functional Lung Impairment in Adult Survivors of Bronchopulmonary Dysplasia.

Steven Caskey1, Aisling Gough1, Stephen Rowan1, Scott Gillespie2, Jim Clarke2, Marshall Riley3, Jacqui Megarry3, Paul Nicholls4, Chris Patterson5, Henry L Halliday6, Michael D Shields1, Lorcan McGarvey1.   

Abstract

RATIONALE: As more preterm infants recover from severe bronchopulmonary dysplasia (BPD), it is critical to understand the clinical consequences of this condition on the lung health of adult survivors.
OBJECTIVES: To assess structural and functional lung parameters in young adult BPD survivors and preterm and term control subjects.
METHODS: Young adult survivors of BPD (mean age, 24 yr) underwent spirometry, lung volume assessment, transfer factor, lung clearance index, and fractional exhaled nitric oxide measurements, together with high-resolution chest computed tomography and cardiopulmonary exercise testing.
MEASUREMENTS AND MAIN RESULTS: Twenty-five adult BPD survivors (mean ± SD gestational age, 26.8 ± 2.3 wk; birth weight, 866 ± 255 g), 24 adult prematurely born non-BPD control subjects (gestational age, 30.6 ± 1.9 wk; birth weight, 1,234 ± 207 g), and 25 adult term-birth control subjects (gestational age, 38.5 ± 0.9 wk; birth weight, 3,569 ± 2,979 g) were studied. Subjects with BPD were more likely to be wakened by cough (odds ratio, 9.7; 95% confidence interval, 1.8-52.6; P < 0.01) or wheeze and breathlessness (odds ratio, 12.2; 95% confidence interval; 1.3-112; P < 0.05) than term control subjects after adjusting for sex and current smoking. Preterm subjects had greater airway obstruction than term subjects. Subjects with BPD had significantly lower values for FEV1 and forced expiratory flow, midexpiratory phase (percent predicted and z-scores), than term control subjects (both P < 0.001). Although non-BPD subjects also had lower spirometric values than term control subjects, none of the differences reached statistical significance. More subjects with BPD (25%) had fixed airflow obstruction than non-BPD (12.5%) and term (0%) subjects (P = 0.004). Both BPD and non-BPD subjects had significantly greater impairment in gas transfer (Kco percent predicted) than term subjects (both P < 0.05). Eighteen (37%) preterm participants were classified as small for gestational age (birth weight below the 10th percentile for gestational age). These subjects had significantly greater impairment in FEV1 (percent predicted values and z-scores) than those born appropriate for gestational age. BPD survivors had significantly more severe radiographic structural lung impairment than non-BPD subjects. Both preterm groups had impaired exercise capacity compared with term control subjects. There was a trend for greater limitation and leg discomfort in BPD survivors.
CONCLUSIONS: Adult preterm birth survivors, especially those who developed BPD, continue to experience respiratory symptoms and exhibit clinically important levels of pulmonary impairment.

Entities:  

Keywords:  adult; bronchopulmonary dysplasia; chronic lung disease

Mesh:

Year:  2016        PMID: 27222921     DOI: 10.1513/AnnalsATS.201509-578OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  29 in total

1.  Serum neurotrophins at birth correlate with respiratory and neurodevelopmental outcomes of premature infants.

Authors:  Samantha L Simpson; Stephanie Grayson; Jennifer H Peterson; John J Moore; Maroun J Mhanna; Miriam K Perez; Fariba Rezaee; Giovanni Piedimonte
Journal:  Pediatr Pulmonol       Date:  2018-12-21

2.  Fatty Acid Oxidation Protects against Hyperoxia-induced Endothelial Cell Apoptosis and Lung Injury in Neonatal Mice.

Authors:  Hongwei Yao; Jiannan Gong; Abigail L Peterson; Xuexin Lu; Peng Zhang; Phyllis A Dennery
Journal:  Am J Respir Cell Mol Biol       Date:  2019-06       Impact factor: 6.914

3.  [Dynamic observation of pulmonary function by plethysmography in preterm infants with bronchopulmonary dysplasia].

Authors:  Jing Zhang; Ling-Ping Zhang; Lan Kang; Xiao-Ping Lei; Wen-Bin Dong
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2019-12

4.  Cumulative effects of neonatal hyperoxia on murine alveolar structure and function.

Authors:  Angela M Cox; Yong Gao; Anne-Karina T Perl; Robert S Tepper; Shawn K Ahlfeld
Journal:  Pediatr Pulmonol       Date:  2017-02-10

5.  Early Pulmonary Vascular Disease in Young Adults Born Preterm.

Authors:  Kara N Goss; Arij G Beshish; Gregory P Barton; Kristin Haraldsdottir; Taylor S Levin; Laura H Tetri; Therese J Battiola; Ashley M Mulchrone; David F Pegelow; Mari Palta; Luke J Lamers; Andrew M Watson; Naomi C Chesler; Marlowe W Eldridge
Journal:  Am J Respir Crit Care Med       Date:  2018-12-15       Impact factor: 21.405

6.  The Effect of Preterm Birth on Maximal Aerobic Exercise Capacity and Lung Function in Healthy Adults: A Systematic Review and Meta-analysis.

Authors:  Thomas Gostelow; Eric J Stöhr
Journal:  Sports Med       Date:  2022-06-27       Impact factor: 11.928

7.  Neonatal therapy with PF543, a sphingosine kinase 1 inhibitor, ameliorates hyperoxia-induced airway remodeling in a murine model of bronchopulmonary dysplasia.

Authors:  Alison W Ha; Tara Sudhadevi; David L Ebenezer; Panfeng Fu; Evgeny V Berdyshev; Steven J Ackerman; Viswanathan Natarajan; Anantha Harijith
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-07-22       Impact factor: 5.464

8.  Endothelial to mesenchymal transition during neonatal hyperoxia-induced pulmonary hypertension.

Authors:  Jiannan Gong; Zihang Feng; Abigail L Peterson; Jennifer F Carr; Alexander Vang; Julie Braza; Gaurav Choudhary; Phyllis A Dennery; Hongwei Yao
Journal:  J Pathol       Date:  2020-10-06       Impact factor: 7.996

9.  Bronchopulmonary dysplasia as a determinant of respiratory outcomes in adult life.

Authors:  Joseph M Collaco; Sharon A McGrath-Morrow
Journal:  Pediatr Pulmonol       Date:  2021-03-17

Review 10.  Respiratory and cardiopulmonary limitations to aerobic exercise capacity in adults born preterm.

Authors:  Joseph W Duke; Andrew T Lovering
Journal:  J Appl Physiol (1985)       Date:  2020-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.